Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 December 2023 | Story Anthony Mthembu | Photo SUPPLIED
Albertus Engelbrecht
Albertus Engelbrecht: Lecturer in Singing and Coordinator of Vocal Studies at the Odeion School of Music.

The University of the Free State (UFS) is gearing up to honour a new group of graduates during the upcoming graduation ceremonies on 7-8 December 2023. Among the distinguished individuals set to grace the stage is Albertus Engelbrecht, Coordinator of Vocal Studies at the Odeion School of Music and an internationally recognised opera singer with a career spanning over two decades.

Engelbrecht has achieved a significant milestone, completing his PhD thesis titled “The Journey of a Versatile Singer”. On 7 December 2023, he will formally receive his qualification, marking the culmination of a seven-year academic journey. Reflecting on this achievement, Engelbrecht expressed his relief, stating, “It’s all still so surreal, but I think that the moment I walk onto that stage, then, will it only sink in.’’  

The journey of a versatile singer

His thesis is an auto-ethnographic study that delves into the preparation and performance of five different styles and genres of Western art music. This unique approach includes a practical component, as he actively participated in five different concerts or performances, ultimately contributing to his research. He shared his motivation, stating, ‘’I was investigating how it would be possible to sing different kinds of Western art music styles and genres. The idea came from my professional experience, where I found that to become a successful opera and concert singer, it’s better for one to be able to do different styles and genres.’’  

Looking ahead, Engelbrecht envisions his research making a meaningful impact on the development of emerging singers. He aspires to shape the future of vocal education, stating, “I hope that my contribution leads to new knowledge not only for singers but for their teachers and vocal coaches. This is so that they can approach music in the way it is written, and to find ways which make the music speak the best way it can. In this way, singers can be more versatile.’’  

Future plans

Post-graduation, Engelbrecht has ambitious plans to further his growth within the industry. Expressing his goals, he said, ‘’I would like to grow not just as a performing artist but as a researcher too.” Currently collaborating with his former supervisor on a research project focusing on performance analysis, Engelbrecht aims to delve deeper into the research aspect of his profession. Additionally, as a Lecturer of Singing at the UFS, he looks forward to engaging in more performing projects with his students.

In recognition of Albertus Engelbrecht’s remarkable achievement, the UFS community congratulates him on this significant milestone. His dedication to the field of vocal studies and commitment to fostering versatility in music is truly commendable. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept